Triptans Interactions

Concomitant use of other 5-HT1 agonists (triptans) within 24 hours of almotriptan malate is contraindicated.

Source: NLP:almotriptan malate

Other 5-HT1 agonists (triptans) have additive vasospastic effects with sumatriptan. Coadministration within 24 hours of each other is contraindicated.

Source: NLP:sumatriptan

Other 5-HT1 agonists (triptans) have additive vasospastic effects; contraindicated within 24 hours of sumatriptan succinate.

Source: NLP:sumatriptan succinate

Other 5-HT1 agonists can cause vasospastic effects. Coadministration within 24 hours is contraindicated due to additive vasospastic effects.

Source: NLP:sumatriptan and naproxen sodium

Other 5-HT1B/1D agonists including triptans contraindicated within 24 hours due to risk of additive vasospastic reactions.

Source: NLP:zolmitriptan

Rare postmarketing reports of serotonin syndrome with concurrent use of citalopram and triptans. Careful observation advised, particularly during treatment initiation and dose increases.

Source: NLP:citalopram

Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during initiation and dosage increases.

Source: NLP:citalopram hydrobromide

Serotonergic drugs that increase risk of serotonin syndrome with dextroamphetamine sulfate.

Source: NLP:dextroamphetamine sulfate

Concomitant use may increase risk for supine hypertension due to additive blood pressure-raising effects.

Source: NLP:droxidopa

Rare postmarketing reports of serotonin syndrome with SSRIs and triptans. Careful observation advised if concomitant use clinically warranted.

Source: NLP:escitalopram

Rare postmarketing reports of serotonin syndrome with SSRIs and triptans. Careful observation advised during treatment initiation and dose increases.

Source: NLP:escitalopram oxalate

Increases risk of serotonin syndrome. Monitor patients for signs and symptoms during treatment initiation and dosage increases.

Source: NLP:fluoxetine

Concomitant use increases risk of serotonin syndrome; monitor for symptoms.

Source: NLP:fluoxetine hydrochloride

Concomitant use may result in serotonin syndrome. Frequently evaluate patient during treatment initiation and dose adjustment.

Source: NLP:hydromorphone hydrochloride

Concomitant use has resulted in serotonin syndrome.

Source: NLP:levorphanol tartrate

Concomitant use may result in serotonin syndrome. Carefully observe patient during treatment initiation and dosage modification; discontinue metaxalone if serotonin syndrome occurs.

Source: NLP:metaxalone

Rare postmarketing reports of serotonin syndrome. Careful observation advised if concomitant treatment is clinically warranted.

Source: NLP:milnacipran hydrochloride

Concomitant use increases risk of serotonin syndrome. Monitor for signs and symptoms, particularly during treatment initiation and dosage increases.

Source: NLP:mirtazapine

Concomitant use can result in serotonin syndrome. Requires frequent patient evaluation, particularly during initiation and dose adjustment.

Source: NLP:morphine sulfate

Concomitant use may result in serotonin syndrome. Carefully observe patient during treatment initiation and dose adjustment.

Source: NLP:nalbuphine hydrochloride

Concomitant use with serotonergic drugs has resulted in serotonin syndrome.

Source: NLP:oxymorphone hydrochloride

Concomitant use of serotonergic drugs triptans with paroxetine increases risk of serotonin syndrome.

Source: NLP:paroxetine

Concomitant use has resulted in serotonin syndrome. Carefully observe patient during treatment initiation and dose adjustment.

Source: NLP:pentazocine and naloxone

Concomitant use may result in serotonin syndrome.

Source: NLP:remifentanil hydrochloride

Concomitant use increases risk of serotonin syndrome. Monitor patients for signs and symptoms, particularly during initiation and dosage increases.

Source: NLP:sertraline

Concomitant use increases risk of serotonin syndrome. Monitor patients for signs and symptoms, particularly during treatment initiation and dosage increases.

Source: NLP:sertraline hydrochloride

Concomitant use increases risk of serotonin syndrome. Monitor patients for signs and symptoms during trazodone initiation.

Source: NLP:trazodone hydrochloride

Potential for serotonin syndrome with serotonergic drugs including triptans. Careful patient observation advised.

Source: NLP:venlafaxine

Potential for serotonin syndrome when used with serotonergic drugs. Careful patient observation advised.

Source: NLP:venlafaxine hydrochloride, extended release

Concomitant use increases risk of serotonin syndrome. Monitor for symptoms and consider discontinuation if serotonin syndrome occurs.

Source: NLP:venlafaxine hydrochloride

Risk of serotonin syndrome with concomitant therapy with triptans.

Source: NLP:ziprasidone

Risk of serotonin syndrome with concomitant serotonergic therapy including triptans.

Source: NLP:ziprasidone hydrochloride

Risk of serotonin syndrome with concomitant serotonergic therapy including triptans.

Source: NLP:ziprasidone mesylate

Concomitant use increases risk of serotonin syndrome. Monitor for symptoms and consider discontinuation if serotonin syndrome occurs.

Source: NLP:desvenlafaxine

Concomitant use increases risk of serotonin syndrome. Monitor for symptoms and consider discontinuation if serotonin syndrome occurs.

Source: NLP:desvenlafaxine er

Concomitant use increases risk of serotonin syndrome. Monitor for symptoms and consider discontinuation if serotonin syndrome occurs.

Source: NLP:desvenlafaxine succinate

Serotonergic drugs that increase risk of serotonin syndrome. Monitor for symptoms and discontinue if serotonin syndrome occurs.

Source: NLP:levomilnacipran hydrochloride

Concomitant use of serotonergic drugs with paroxetine increases the risk of serotonin syndrome. Monitor for symptoms.

Source: NLP:paroxetine hydrochloride

Rare postmarketing reports of serotonin syndrome. Careful observation advised if concomitant use is clinically warranted, especially during initiation and dose increases.

Source: NLP:paroxetine hydrochloride hemihydrate

Serotonergic drugs that increase risk of serotonin syndrome; monitor patients for signs and symptoms during initiation.

Source: NLP:vilazodone hydrochloride